pancreatic cancer
FDA Grants Accelerated Approval to Bizengri for NSCLC and Pancreatic Adenocarcinoma
The FDA granted accelerated approval to Bizengri for indications in NSCLC and pancreatic adenocarcinoma.
DECEMBER 5, 2024
Onivyde Approved for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
The FDA approved Onivyde with oxaliplatin, fluorouracil and leucovorin, for the first-line treatment of metastatic ...
FEBRUARY 14, 2024
Progress in Digestive Tract Cancer Treatments Reported at Cancer Meeting
Four new trials presented at ASCO 2023 may help change the way several GI cancers are treated.
SEPTEMBER 22, 2023
Personalized RNA Vaccine May Prolong Life of Patients With Pancreatic Cancer
Data from a small phase 1 study published in Nature indicate that patients with PDAC who respond to ...
MAY 22, 2023
New ASGE Guidelines on Pancreatic Cancer Screening:
The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for ...
JUNE 1, 2022
Researchers Find Possible Connection Between Opioid Use, Pancreatic Cancer
A study has linked opioid use to a slight increase in pancreatic cancer rates at state and national levels.
MAY 5, 2021
Dose-Reduced Chemo Effective in Elderly Patients
In a single-center study of elderly patients with advanced pancreatic cancer, reductions in the dose of gemcitabine ...
OCTOBER 8, 2019
BRCA Mutations Emerging as Risk for Pancreatic Cancer
Although rare, pancreatic cancer is one of the deadliest forms of the disease, simply because it’s often ...
MARCH 20, 2019
